An integral part of the healthcare industry, West’s top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes excellence in manufacturing, scientific and technical expertise, and management. At the manufacturing level, this means producing clean, sterile, high-quality components to minimize disruptions to the supply chain and bringing safe, effective drug products to the market—and to the patient—quickly and efficiently.
We come together as one global team to deliver for our customers and help them address their challenges. We are a diverse, close-knit community of professionals, where everyone has a voice and opportunity to learn and grow through mutual trust and respect. With a history spanning over 95 years, we have a track record for success.
Giving back is in our DNA—our team members across more than 50 sites globally are involved with hundreds of charities that have special meaning to them through our West without Borders team member-led giving program.
- West Announces Second-Quarter Dividendby West Pharmaceutical Services, Inc. News Releases on February 25, 2020 at 11:00 am
EXTON, Pa. , Feb. 25, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2020 dividend of $0.16 per share.
- West Elects New Director to the Boardby West Pharmaceutical Services, Inc. News Releases on February 17, 2020 at 11:00 am
EXTON, Pa. , Feb. 17, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Robert Friel as its newest member. With the addition of Mr.
- West Announces Fourth-Quarter and Full-Year 2019 Resultsby West Pharmaceutical Services, Inc. News Releases on February 13, 2020 at 11:00 am
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 13, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2019 and introduced full-year 2020 financial guidance.